Header

UZH-Logo

Maintenance Infos

Highlights of Novel Vaccination Strategies in Allergen Immunotherapy


Komlósi, Zsolt István; Kovács, Nóra; Sokolowska, Milena; van de Veen, Willem; Akdis, Mübeccel; Akdis, Cezmi A (2020). Highlights of Novel Vaccination Strategies in Allergen Immunotherapy. Immunology and Allergy Clinics of North America, 40(1):15-24.

Abstract

Increasing safety while maintaining or even augmenting efficiency are the main goals of research for novel vaccine development and improvement of treatment schemes in allergen immunotherapy (AIT).1, 2, 3, 4 In spite of encouraging positive experiences,5 AIT still faces several problems related to worldwide standardization, its limited efficacy, potential severe side effects, low patient adherence, high costs, and long duration (3–5 years) of treatment. There have been many different approaches to improve the standardization, efficacy, and safety of AIT in the past, which have been continuously pursued during the past years.6, 7, 8 Currently, efforts on developing novel vaccines of AIT continue for the treatment of asthma,9 allergic rhinoconjunctivitis,10 bee venom allergy,11 and food allergy.12 Similar efforts are being undertaken for autoimmune diseases. Studies to offer prophylactic usage are also being performed.13 Regulatory issues represent an important aspect in this context14 and global and national strategies are being continuously developed.15,16 It is essential to develop strong collaborations with the regulatory authorities for extensive preventive usage of AIT vaccines and usage of pollen chambers for outcome evaluations to avoid slowing down of vaccine developments. Here, the authors summarize some current investigations aiming at further improvement of AIT vaccines (Table 1).

Abstract

Increasing safety while maintaining or even augmenting efficiency are the main goals of research for novel vaccine development and improvement of treatment schemes in allergen immunotherapy (AIT).1, 2, 3, 4 In spite of encouraging positive experiences,5 AIT still faces several problems related to worldwide standardization, its limited efficacy, potential severe side effects, low patient adherence, high costs, and long duration (3–5 years) of treatment. There have been many different approaches to improve the standardization, efficacy, and safety of AIT in the past, which have been continuously pursued during the past years.6, 7, 8 Currently, efforts on developing novel vaccines of AIT continue for the treatment of asthma,9 allergic rhinoconjunctivitis,10 bee venom allergy,11 and food allergy.12 Similar efforts are being undertaken for autoimmune diseases. Studies to offer prophylactic usage are also being performed.13 Regulatory issues represent an important aspect in this context14 and global and national strategies are being continuously developed.15,16 It is essential to develop strong collaborations with the regulatory authorities for extensive preventive usage of AIT vaccines and usage of pollen chambers for outcome evaluations to avoid slowing down of vaccine developments. Here, the authors summarize some current investigations aiming at further improvement of AIT vaccines (Table 1).

Statistics

Citations

Dimensions.ai Metrics
6 citations in Web of Science®
5 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

29 downloads since deposited on 21 Jan 2020
16 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Immunology and Allergy
Life Sciences > Immunology
Uncontrolled Keywords:Immunology, Immunology and Allergy
Language:English
Date:1 February 2020
Deposited On:21 Jan 2020 16:41
Last Modified:29 Jul 2020 13:01
Publisher:Elsevier
ISSN:0889-8561
OA Status:Hybrid
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1016/j.iac.2019.09.010
PubMed ID:31761116

Download

Hybrid Open Access

Download PDF  'Highlights of Novel Vaccination Strategies in Allergen Immunotherapy'.
Preview
Content: Published Version
Filetype: PDF
Size: 401kB
View at publisher
Licence: Creative Commons: Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)